跳到正文
原文
Medical Xpress·· 22 天前AI 评分52

Mayo Clinic 研究显示基因检测有助更早识别镰状细胞贫血与β地中海贫血携带状态

Genetic testing may help identify inherited blood disorder carrier status earlier

AI 导读

Mayo Clinic 团队基于 Tapestry 项目近5万名参与者的外显子测序数据,发现基因检测可识别镰状细胞贫血与β地中海贫血的携带状态。116名经基因检测确认的镰状细胞特质者中仅19人有对应诊断编码,98名β地中海贫血携带者中47人有对应编码。研究者认为,更早识别携带状态可为孕前遗传咨询与家庭生育规划提供机会。

正文
genetic test
Credit: CC0 Public Domain

Mayo Clinic researchers have found that genetic testing can help identify people who carry inherited blood disorder traits, including individuals who may not otherwise know their carrier status. Earlier identification can create opportunities for genetic counseling, informed family planning and appropriate clinical follow-up.

Using genetic data from nearly 50,000 participants, Mayo Clinic researchers identified carrier traits for sickle cell anemia and beta-thalassemia at clinically significant levels. Published in Mayo Clinic Proceedings, the study shows how population-scale genetic testing may complement existing screening approaches and provide patients and clinicians with additional information about inherited health risks.

"If we can identify carrier status earlier, we have more opportunities for reproductive counseling, appropriate preventive care and helping patients understand what these findings may mean for their families," says Nathaniel Miller, M.D., a Mayo Clinic family medicine physician and first author of the study.

Screening practices have evolved over time. All U.S. states screen newborns for clinically significant hemoglobinopathies such as sickle cell disease, but practices for identifying and reporting carrier status have varied, particularly for thalassemias. Some adults also were born before comparable newborn screening was available. The findings illustrate how genetic testing later in life may provide health information that was not available earlier.

Genetic testing provides additional insight into carrier status

Sickle cell anemia and beta-thalassemia are hemoglobinopathies—inherited disorders that affect hemoglobin, the protein in red blood cells that carries oxygen throughout the body. In sickle cell anemia, abnormal hemoglobin causes some red blood cells to become rigid, sticky and misshapen, which can slow or block blood flow. Beta-thalassemia reduces the body's production of hemoglobin and can lead to anemia. People with sickle cell trait or beta-thalassemia trait often have few or no symptoms, but they can pass the genetic change to their children.

The research used data from Tapestry, which enrolled more than 98,000 participants across Mayo Clinic between July 2020 and May 2024. The initiative generated whole exome sequencing data to support clinical care, research discovery and genomic education. Researchers analyzed genetic data from nearly 50,000 participants for variants associated with sickle cell trait and beta-thalassemia trait and compared those findings with diagnosis codes in participants' electronic health records.

Among 116 participants identified through genetic testing with sickle cell trait, 19 had a corresponding diagnosis code. Among 98 participants identified as carriers of beta-thalassemia, 47 had a corresponding diagnosis code. The differences illustrate how genetic testing can add information to a person's health history, particularly when carrier status may not have been identified through earlier screening.

Researchers also found instances in which existing diagnosis codes did not correspond with the genetic findings. The authors say additional research is needed to understand these differences, which may reflect variations in historical screening, classification and documentation practices.

Moving toward earlier identification

The findings point to opportunities to develop clearer guidance for identifying hemoglobinopathy carrier status and determining when genetic testing and counseling may be appropriate. Primary care clinicians may be particularly well positioned to help identify people who could benefit from testing before pregnancy.

"From a primary care and population health perspective, the goal is to identify carrier status early, ideally before pregnancy, because many people don't know they are carriers," says Isa Houwink, M.D., Ph.D., a Mayo Clinic family medicine physician and senior author of the study. "That creates an important opportunity for preconception counseling and informed family planning."

The research aligns with Mayo Clinic's broader Precure Research initiative, which focuses on developing tools and approaches to identify disease-related risk earlier, before symptoms emerge or conditions become more difficult to treat.

Publication details

Nathaniel E. Miller et al., Population Genetic Screening of Hemoglobinopathy Carrier Prevalence Compared to Medical Records, Mayo Clinic Proceedings (2026). DOI: 10.1016/j.mayocp.2026.05.021

Journal information: Mayo Clinic Proceedings

Who's behind this story?

Gaby Clark

Gaby Clark

MA in English, copy editor since 2021 with experience in higher education and health content. Dedicated to trustworthy science news. Full profile →

Andrew Zinin

Andrew Zinin

Master's in physics with research experience. Long-time science news enthusiast. Plays key role in Science X's editorial success. Full profile →

Citation: Genetic testing may help identify inherited blood disorder carrier status earlier (2026, October 29) retrieved 29 October 2026 from https://medicalxpress.com/news/2026-10-genetic-inherited-blood-disorder-carrier.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

来源:Medical Xpress · medicalxpress.com